Metabolic Signatures of Tumor Responses to Doxorubicin Elucidated by Metabolic Profiling in Ovo.
Iman W AchkarSara KaderShaima S DibKulsoom JunejoSalha Bujassoum Al-BaderShahina HayatAditya M BhagwatXavier RoussetYan WangJean VialletKarsten SuhreAnna HalamaPublished in: Metabolites (2020)
Metabolomics in combination with in ovo tumor models provide a robust platform for drug testing to reveal tumor specific treatment targets such as the antioxidative tumor capacity.